Unraveling the molecular mechanisms behind mediating the immunomodulatory effect of HSP as immunostimulatory (induction) and immunosuppressive (regulatory activity) provides a new insight clinically for developing better strategies in the relevance of HSPs as therapeutic targets or agents for fighting drug resistance in cancer with improved efficacy. Here, HSP90B2P is linked to cancer.